ProjectKlinische Studie
Basic data
Title:
Klinische Studie
Duration:
01/08/2017 to 01/08/2019
Abstract / short description:
A Randomized, Controlled, Multicenter, Open Label Study with Blinded Assessment of the Efficacy of the Humanized Anti-IL-23p19 Risankizumab Compared to FUMADERM® in Subjects with Moderate to Severe Plaque Psoriasis Who are Naïve to and Candidates for Systemic Therapy
Keywords:
psoriasis
Schuppenflechte
psoriasis therapeutics
Psoriasis Therapeutika
clinical trial
klinische Studie
dermatology
Dermatologie
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Wiesbaden, Hessen, Germany